Image

2019 Cannabis Business Award's

Publication of the Year

WEDNESDAY, APRIL 9, 2025

 

FMCPG HAS BEEN SERVING

AND REPRESENTING THE CANNABIS PHYSICIAN COMMUNITY

SINCE 2020

 

 

FMCPG MEETING

LINK BELOW 

JOIN THE NEXT MEETING OF THE FMCPG
THURSDAY

APRIL 10, 2025

THE

"FLORIDA MEDICAL CANNABIS

PHYSICIAN GROUP"

(FMCPG)

FOR ALL

"MEDICAL MARIJUANA DOCTORS"

AND "MMTC DIRECTORS ONLY "

 

GUEST SPEAKER

BRADY COBB
CEO/FOUNDER - SUNBURN CANNABIS

WILL PRESENT 

"UPDATES ABOUT THE BILLS MOVING IN TALLAHASSEE THAT EFFECT THE WAY YOU OPERATE YOUR BUSINESS"

 

DISCUSSION WILL INCLUDE:

 

LEGISLATIVE  AGENDA FOR 2025

 

TRUMP APPOINTMENTS EFFECT ON THE CANNABIS INDUSTRY IN FLORIDA 

 

REVIEW OF THE OMMU AND  CHANGES TO THE DOCTOR'S PATIENT INPUT PORTAL ON THE OMMU WEBSITE. 

DOCTORS WITHIN OUR GROUP WILL DISCUSS HOW THEY HAVE BEEN WORKING AROUND SOME OF THE CHANGES

 

REF'S ISSUES AND SOLUTIONS

 

USE THIS LINK TO JOIN MEETING TO  PRE- REGISTRATION - THURSDAY, APRIL 10, 2025

 

CLICK HERE ON LINK BELOW

https://us02web.zoom.us/meeting/register/eAiv_F4ZSHujO7JmOZcVaw

 

Meeting ID: 878 4462 8121
Passcode: 354544

JOIN THE FMCPG
MEETING

THURSDAY 

APRIL 10,  2025
 
 

 MEDICAL CANNABIS PHYSICIAN

PROMOTION PACKAGE BY

CANNABIS NEWS FLORIDA 

 

ARTICLE: Physician will contribute an article of 350 words**. This article will appear in the Cannabis News Florida e-newsletter for one month (4 weeks).

 

E-MAIL BLAST: Cannabis News Florida will send out one e-mail blast promoting the Physician to the other physicians in three zip code areas or one city to be determined by the Physician. The Physician will supply the information for the email blast. The Article above can be used in the e-mail blast.

 

The cost of this program is ONLY $500.

 

**Cannabis News Florida will assign a writer for a telephone interview with the Physician and create the article to be published. Physician shall have the right to review and approve the article before publication for an additional cost of $100.

 

IF YOU ARE INTERESTED, PLEASE EMAIL ME AT CHARLES@CANNABISNEWSFLORIDA.COM OR CALL MY CELL AT 954-605-4785

 
 

RESEACH SURVEY FOR FLORIDA MEDICAL CANNABIS PHYSICIANS 

 

PLEASE HELP DR MELANIE BONE, MD, FACOG WITH HER RESEACH BY COMPLETING THIS SURVEY, IT SHOULD ONLY TAKE ABOUT FIVE MINUTES.

 

PLEASE USE THIS LINK FOR THE SURVEY:

 

https://tnstateu.az1.qualtrics.com/jfe/form/SV_cSUteiMg4Hqg9Dw

 

THANK YOU. 

 
 

NEWS FROM THE PAST WEEK

RELATING TO THE BUSINESS OF

MMTC'S

IN FLORIDA

 

Click on Company Logo to be Transferred to Web Site

Trulieve to Open Medical Cannabis Dispensary in St. Petersburg, Florida

New Pinellas County location will host grand opening celebration Friday, April 11th

TALLAHASSEE, Fla., April 9, 2025  — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in St. Petersburg, Florida.

A grand opening celebration will be held Friday, April 11th, beginning at 9 a.m., featuring music, specials, discounts, and opportunities to register for upcoming patient education sessions.

“This new dispensary provides St. Petersburg patients and caregivers an accessible location with a drive-through option,” said Trulieve’s Chief Executive Officer Kim Rivers. “We are proud to serve patients in Pinellas County with high quality medical cannabis products.”

Trulieve St. Pete Central, located at 3210 Central Avenue, will be open 9 a.m. – 8:30 p.m. Monday through Saturday and 11 a.m. – 8 p.m. on Sundays, offering drive-through, walk-in, and express pickup service.

The new dispensary will carry a wide variety of popular products including Trulieve’s portfolio of in-house brands such as Alchemy, Co2lors, Cultivar Collection, Modern Flower, Momenta, Muse, Roll One, Sweet Talk, and Trekkers. Customers will also have access to beloved partner brands such as Alien Labs, Bellamy Brothers, Binske, Black Tuna, Blue River, Connected Cannabis, DeLisioso, Khalifa Kush, Love’s Oven, Miami Mango, Seed Junky, and Sunshine Cannabis, all available exclusively at Trulieve in Florida.

READ MORE

 
 

CLICK HERE FOR MORE INFORMATION ABOUT THE SUNBURN CANNABIS PROMOTIONS

 
 
 

AYR Wellness Announces Changes to Management

MIAMI, April 4, 2025  — AYR Wellness Inc. (“AYR” or the “Company”) (CSE: AYR.A, OTCQX: AYRWF) a leading vertically integrated U.S. multi-state cannabis operator, announced that, effective today, Steven M. Cohen has stepped down as the Interim Chief Executive Officer of the Company. The AYR board of directors (the “Board”) has appointed Scott Davido as Interim Chief Executive Officer. Mr. Cohen served as Interim Chief Executive Officer from September 18, 2024, and will remain engaged as an advisor to the Company to support this transition.

Mr. Davido is a senior managing director at Ankura Consulting Group, a global advisory and business consulting firm. He previously served in the same role at FTI Consulting, leading companies in financial and operational transitions. Among his roles, Mr. Davido has previously served as Interim CEO of DCL Corporation, CEO of Advantage Rent a Car, and CEO of Experience.com (formerly Social Survey). Mr. Davido has also held senior executive roles at Calpine Corporation and NRG Energy.

READ MORE

 
 
 
 
 

FLUENT Expands Hyer Kind Brand to the New York Market

Live Rosin Infused Pre-Rolls now available in New York
NEW YORK, April 04, 2025 — FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), a national cannabis company operating under the FLUENT™ brand, is proud to announce the launch of Hyer Kind, a cosmic voyage into the world of premium cannabis, in the state of New York. Hyer Kind’s expertly crafted live rosin-infused pre-rolls “Boosters” are now available at all adult-use FLUENT retail stores throughout New York and its rapidly growing wholesale channels statewide. Designed for exceptional flavor and quality, these pre-rolls cater to the rising demand for infused options in the Empire State.

“We are thrilled to expand access to Hyer Kind products beyond Florida and now into New York,” said Robert Beasley, CEO of FLUENT. “As we grow our brand and product portfolio in New York, we remain committed to aligning our menu selection with Florida, ensuring consistency and familiarity for our patients and customers nationwide.”

READ MORE

 
 
 
 
 
 
 
 
 
 

FINO BRANDS, INC

 
 
 
 
 
 

PROSPERITY MEDICAL, LLC

 

THERATRUE FLORIDA

 
 

M&A Activity by Industry Sector 2025 vs. 2024

The Cultivation & Retail sector leads all sectors in total M&A transaction value with $589.9M in total deal consideration for the LTM period ended 4/4/25.  This level of activity reflects continued consolidation among U.S. licensed operators.  As Viridian has been highlighting over the past year this includes "intra-state" roll-ups by leading Single-State Operators ("SSOs").

The Infused Products & Extracts sector ranks second in total M&A consideration at $421.1M for this period.  This level of activity reflects the increasing prominence of branded products in the sector, including hemp-derived infused products.

The Real Estate sector ranks third in total M&A consideration at $58.9M for this period.

 

View This Week's Viridian Sector Deal Tracker For a Deeper Dive Into M&A and Capital Raise Transactions by Industry Sector

Wondering What Your Cannabis Business Is Worth?  Contact Us We'll Give You the Facts From Our Proprietary Deal Data

 

About The Viridian Cannabis Deal Tracker

Launched in January 2015, and having analyzed more than $75B in deals, the Viridian Cannabis Deal Tracker is a proprietary data service that monitors and analyzes capital raise and M&A activity in the legal Cannabis, Hemp, and Psychedelics industries. Our insights help companies, investors, lenders and acquirers make informed capital allocation decisions.  Each week the Deal Tracker provides proprietary data and market intelligence on transactions, including:

- Deals by Industry Sector (Track the Flow of Capital and M&A Deals by Industry Sector)

- Deal Structure (Equity/Debt for Capital Raises, Cash/Stock/Earnout for M&A)

- Principals to the Transaction (Issuer/Investor/Lender/Acquirer)

- Key Deal Terms (Deal Size, Valuation, Pricing, Warrants, Cost of Capital)

- Deals by Location of Issuer/Buyer/Seller (Track the Flow of Deals by State and Country)

- Credit Ratings (Leverage and Liquidity Ratios)


Contact
Scott Greiper
CEO
Viridian Capital Advisors, LLC
646.330.0704
sgreiper@viridianca.com

Broker-Dealer Services Provided Through Bradley Woods & Co. Ltd. - A Member of FINRA and SIPC, 
845 Third Avenue, Suite 1703, New York, N.Y. 10022

 

 

 
 

NATIONAL AND INTERNATIONAL NEWS


Tilray Brands Reports Q3 Fiscal 2025 Financial Results

Tilray Confirms No Current Impact of Tariffs

Generated Net Revenue of $186 Million in the Third Quarter, $193 Million in Constant Currency; Strategic Initiatives and SKU Rationalization Impacted Revenue by $13 Million

Tilray Beverage Expands U.S. Distribution of Hemp-Derived THC Drinks Across 10 States, Increases Project 420 Cost Savings Plan to $33 Million

Tilray Cannabis Increased Gross Margins by 800 bps, Remains the Leader in Canada by Sales Performance, and Generates Strong Sales Growth in Germany

Strengthens Balance Sheet with Convertible Note Reduction of $58 Million and Total Debt Reduction of $71 Million, $248 Million Available in Cash and Marketable Securities

NEW YORK and LEAMINGTON, Ontario, April 08, 2025 —  Tilray Brands, Inc. (“Tilray”, “our”, “we” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, today reported financial results for its third quarter ended February 28, 2025. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated.

In response to the recently announced tariffs on international trade, Tilray conducted an analysis of the potential implications on its business. The analysis concluded that these tariffs should not impact sales. In the United States, Tilray’s American beverage brands are solely manufactured and distributed within the U.S. market. In Canada, Tilray’s cannabis brands are produced domestically for Canadian consumers. In Europe, Tilray manufactures medical cannabis brands and products for distribution across Europe and Australia. Regarding Tilray’s wellness business, Manitoba Harvest is currently exempt from the new tariffs.

Irwin D. Simon, Chairman and Chief Executive Officer of Tilray Brands, stated, “Tilray Brands is shaping the future of consumer markets with a robust global infrastructure spanning the beverage, cannabis, and wellness industries. We are meeting the needs of today’s consumers while preparing for the demands of tomorrow. In the third quarter, we prioritized sales quality and revenue, protected margins, reduced debt, and improved our capital structure. With a strong balance sheet and a clear vision for the future, Tilray is well positioned to capitalize on emerging opportunities and ensure long-term success.”

READ MORE

 

Atwater Brewery Releases Atwater Light: Detroit’s Premium Light Craft Beer

Atwater Light Brings a Crafted Touch to Low-Calorie beer, Inspired by the Spirit of Detroit
DETROIT, April 07, 2025 — Atwater Brewing, Detroit’s renowned craft brewery and a craft beer brand of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is pleased to announce the launch of Atwater Light, a low-calorie, low-carb addition to its flagship line available year-round. This new product is now offered at local retailers and all three Atwater Tap Rooms and is anticipated to become a preferred choice for beer enthusiasts throughout Michigan.

Atwater Light is a light-bodied, refreshing brew with only 95 calories, 2.6 carbs per 12 oz serving, and 4.2% ABV. Crafted with German Noble hops for a traditional flavor and aroma, and Vienna malt for the perfect body and color, this beer offers a delightful drinking experience without the extra calories.

Carrie Shafir, Senior Brand Director at Tilray Beverages, stated, “Atwater’s beers honor the spirit of Detroit, and we brew our products for the hardworking people that work and live in this city. We are proud of our brewing heritage and community, and with the introduction of Atwater Light, we offer an honest light lager that suits any occasion, designed for maximum refreshment.”

READ MORE

 

Canopy Growth Strengthens Balance Sheet with Optional Early Prepayment to Reduce Term Loan by US$100 Million

SMITHS FALLS, ON. April 1, 2025 — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today that it has made an optional early prepayment under its senior secured term loan (the “Term Loan”) in an aggregate principal amount equal to US$100 million at a discounted price of US$97.5 million. This results in interest expense savings of approximately US$13 million on an annualized basis.

“Canopy has further improved its balance sheet with this early prepayment by reducing our overall debt position as well as lowering annual interest costs,” said Judy Hong, CFO of Canopy Growth. “In addition, with this prepayment now made, we have no material debt obligation until September 2027.”

READ MORE

 

Canopy Growth and Spectrum Therapeutics Announce Spectrum Reserve, A New Premium Medical Cannabis Brand

New Brand Features Premium Genetics, Selected for Potency, Terpenes, and Consistency

SMITHS FALLS, ON. April 2, 2025 — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has launched Spectrum Reserve, a new premium medical cannabis brand in Canada. Designed to meet the evolving needs of medical cannabis patients, Spectrum Reserve represents the peak of cannabis cultivation – featuring flower selected for size, potency, and terpene levels through rigorous in-house standards during cultivation and post-harvest.

Under this new program, Spectrum Reserve is expected to introduce new strains on a regular basis based on patient needs, preferences, and feedback. The strains which generate the most positive and consistent customer feedback will remain in market, while others will be phased out to make way for new genetics through a process of constant enhancement. This approach will help Spectrum Therapeutics consistently deliver new, premium quality strains to the medical cannabis market in Canada.

READ MORE

 

BELOW ARE THE  LINKS TO THE DIRECTORY OF FLORIDA CANNABIS DOCTORS AND

DISPENSARIES IN THE STATE OF FLORIDA

Link to current Qualified Medical Marijuana Physicians in Florida>

Listing of MMTC dispensing facilities>

 

SUMMARY OF THE MEDICAL CANNABIS PROGRAM IN FLORIDA ANNUAL REPORT JULY 2022- JUNE 2023

 

CLICK ON IMAGE BELOW FOR A PDF COPY

 

 QUALIFIED PATIENTS

OVER 907,000

AND

713

DISPENSING LOCATIONS

Image

LATEST OMMU REPORTS FROM OFFICE OF MEDICAL  MARIJUANA USE IN THE STATE OF FLORIDA

Highlights from 
APRIL 4, 2025

Report 

BY THE NUMBERS

Qualified Patients: (Active ID Card)

APR    04   2025-            907,575

MAR   28   2025-             905,556

MAR   21   2025-             905,006

MAR   14   2025-             903,790

MAR    07  2025-             902,566

FEB     28  2025-             902,647  

 

Patients Last Week: 2,019

Qualified Ordering Physicians: 2,391

New Doctors Last Week: 0

 

Reporting Period:  MAR 28 - APR 3, 2025 

Amount of Medical Marijuana Dispensed -  (mgs THC) 400,000,348

Amount of Low-THC Cannabis Dispensed -  (mgs CBD) 33,195

Amount of Marijuana in a From for Smoking (oz) 133,999.886

Approved Dispensing Locations: 713

 

Added Last Week: 2

COOKIES- ORANGE PARK

JUNGLE BOYS - NEW SMYRNA BEACH

CLICK HERE FOR CURRENT OMMU REPORT
Alternate text
 

UPCOMING MEETING AND CONFERENCES

 
 

EMAIL ME FOR SPECIAL DISCOUNT CODE FOR

FLORIDA MEDICAL CANNABIS PHYSICIANS GROUP MEMBERS

CHARLES FELIX - charles@cannabisnewsflorida.com

 
https://www.cannectd.com/
 
 

 In Case You Missed It:

Watch the MedCannCon24 Conference Recording!

We are excited to announce that the recording of SCC's October 2024 Medical Cannabis Conference is now available for purchase. 

 

This 2nd annual event brought together clinicians, researchers, experts, and advocates in the medical cannabis space to share groundbreaking insights, clinical applications, and the latest updates in cannabis science and policy. If you were unable to attend the conference or watch the livestream, this is your chance to access the wealth of information presented. 

 

All proceeds from this recording will support our mission to provide continuing education about the medical uses of cannabis and best practices in clinical care. 

 

View the conference agenda HERE.  

 

Thank you for your continued support in helping us build a more informed and empowered community!

 

Click the link below to purchase the recording. 

 

PURCHASE THE RECORDING

 
 

ADVERTISEMENT OPPORTUNITIES

 

If your goal is to get your business in front of the right people in the cannabis industry or you want to be an integral part of this new and exciting business opportunity, then you need to join with Cannabis News Florida as we help to establish cannabis as a major part of the economy in Florida. Cannabis News Florida is an online publication focusing on both local and national news from leading authorities about the medical and business developments in the medical cannabis industry covering the entire state of Florida.

 

Join the Cannabis News Florida force online and in print. We offer several marketing options to fit all budgets:

· MMTC PROMOS LISTED IN EACH E-NEWSLETTER 
• Directory Listing
• Banner Ads
• Ad Space in the Newspaper
• Feature Articles
• Weekly Newsletters


For further information or to make your ad reservation, please call:561-368-6950 / 954-605-4785 cell charles@cannabisnewsflorida.com

 

Click Here to Unsubscribe

 

CANNABIS NEWS FLORIDA

{YOURCOMPANY.ADDRESS}

{COPYRIGHT.YEAR}